Using Hearing Aids Linked to 23% Reduced Dementia Risk in Epilepsy Patients

Hearing Aids May Lower Dementia Risk in Epileptic Patients

The use of hearing aids has recently been highlighted in a study presented at the European Academy of Neurology (EAN) Congress in 2026. The research focuses on adults suffering from both epilepsy and hearing loss, presenting compelling evidence that the use of hearing aids can reduce their risk of developing dementia by 23%. This relationship underscores the critical role hearing aids can play in cognitive health, particularly for vulnerable populations.

The Study's Findings

According to the findings from researchers at the University Hospital of Zurich and the University of Liverpool, the study analyzed electronic health records from over 250 million patients within the TriNetX network. The comparison was made between adults with hearing loss who used hearing aids and those who did not. Notably, the research encompassed a wide range of health conditions amongst the subjects, including cerebrovascular accidents, type 2 diabetes, chronic kidney disease, heart failure, migraines, and osteoarthritis.

While the general population of individuals with hearing loss showed no significant association between hearing aid use and dementia risk, the subset of adults with epilepsy did reveal a noteworthy result. The study found that among the patients with both epilepsy and hearing loss, using hearing aids correlated with a 23% decrease in the likelihood of developing dementia. This translates to an absolute reduction of 2.7 percentage points over five years, suggesting that one less case of dementia could arise for every 37 individuals utilizing hearing aids.

Understanding the Mechanism

Dr. Carolina Ferreira-Atuesta, the lead author of the study, offered insights into why this correlation might exist. She explained that many individuals with hearing loss possess sufficient cognitive reserve—the brain's ability to compensate for aging or neurological damage—to manage their auditory disabilities effectively. By correcting hearing loss, it isn't necessarily expected to significantly impact dementia risk in these cases. However, individuals with epilepsy often have diminished cognitive reserves, which might mean removing additional stressors, such as hearing impairment, would yield a more significant benefit.

Dr. Ferreira-Atuesta elaborated, "There are several biologically plausible explanations for this observed effect in epilepsy. This condition tends to accompany accelerated cognitive decline, and specific types of epilepsy can affect regions of the brain associated with hearing. Furthermore, certain anti-seizure medications might exacerbate auditory issues."

Clinical Implications

The insights gained from this research carry substantial implications for clinical practices. Given that patients with epilepsy regularly interact with healthcare services, the incorporation of hearing evaluations into standard care could be implemented relatively easily. By identifying hearing loss earlier and advising the use of hearing aids, healthcare providers may play a crucial role in not only enhancing quality of life for their patients but also potentially safeguarding their cognitive health.

In summary, this groundbreaking study sheds light on the importance of addressing hearing loss in patients with epilepsy as a means to help mitigate the risk of dementia. The direct link proven through empirical data establishes a compelling case for further integrating auditory health into neurological care pathways. As research continues to unfold, the healthcare community is encouraged to examine the broader applications of these findings in related fields of study.